Non syndromic primary diffuse leptomeningeal melanomatosis in a child: a case report
Iranian Journal of Child Neurology,
Vol. 15 No. 3 (2021),
1 July 2021
https://doi.org/10.22037/ijcn.v15i2.20159
Abstract
Abstract
In this study, a case of primary diffuse leptomeningeal melanomatosis (PDLM), without neurocutaneous melanosis syndrome, is presented. A female patient (age, 14 years) presented with headache, nausea, vomiting, vertigo, diplopia, and lower limb weakness. Definitive histological examination showed a densely cellular tumor, characterized by irregular clusters of large pleomorphic cells and melanin in tumor cells. Adjuvant therapy was refused by the parents, and the patient died within 6 months. PDLM is recognized as an uncommon and malignant melanoma affecting the central nervous system. In case comorbidities are not diagnosed in patients with unusual symptoms of meningitis, diagnostic methods such as cerebrospinal fluid analysis and CNS biopsy can be helpful in identifying other underlying conditions.
- Spine
- Central nervous system
- Melanoma
- Child
How to Cite
References
Liubinas SV, Maartens N, Drummond KJ. Primary melanocytic neoplasms of the central nervous system. J Clin Neurosci. 2010;17(10):1227-32.
Hsieh YY, Yang ST, Li WH, Hu CJ, Wang LS. Primary leptomeningeal melanoma mimicking meningitis: a case report and literature review. J Clin Oncol. 2015;33(12):e57-61.
Di Rocco F, Sabatino G, Koutzoglou M, Battaglia D, Caldarelli M, Tamburrini G. Neurocutaneous melanosis. Childs Nerv Syst. 2004;20(1):23-8.
Zadro I, Brinar VV, Barun B, Ozretic D, Pažanin L, Grahovac G, et al. Primary diffuse meningeal melanomatosis. The neurologist. 2010;16(2):117-9.
Szathmari A, Perbet R, Hermier M, Di Rocco F, Frappaz D, Mottolese C. Primary Amelanotic Leptomeningeal Melanomatosis in a Child: A Rare but Severe Disease. World Neurosurgery. 2016;92:581. e15-. e20.
Tolleson WH. Human melanocyte biology, toxicology, and pathology. Journal of Environmental Science and Health Part C. 2005;23(2):105-61.
Painter TJ, Chaljub G, Sethi R, Singh H, Gelman B. Intracranial and intraspinal meningeal melanocytosis. American journal of neuroradiology. 2000;21(7):1349-53.
Nicolaides P, Newton RW, Kelsey A. Primary malignant melanoma of meninges: atypical presentation of subacute meningitis. Pediatric neurology. 1995;12(2):172-4.
Lee HJ, Ahn B-C, Hwang SW, Cho SK, Kim HW, Lee S-W, et al. F-18 fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal melanomatosis. Korean journal of radiology. 2013;14(2):343-9.
Barkovich A, Frieden I, Williams M. MR of neurocutaneous melanosis. American journal of neuroradiology. 1994;15(5):859-67.
Hayashi M, Maeda M, Maji T, Matsubara T, Tsukahara H, Takeda K. Diffuse leptomeningeal hyperintensity on fluid-attenuated inversion recovery MR images in neurocutaneous melanosis. American journal of neuroradiology. 2004;25(1):138-41.
Kim D-H, Choi C-Y, Lee C-H, Joo M. Primary Intracranial Leptomeningeal Melanomatosis. Journal of Korean Neurosurgical Society. 2015;58(6):554-6.
Lee C-H, Moon KY, Chung CK, Kim H-J, Chang K-H, Park S-H, et al. Primary intradural extramedullary melanoma of the cervical spinal cord: case report. Spine. 2010;35(8):E303-E7.
Harstad L, Hess KR, Groves MD. Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Neuro-oncology. 2008;10(6):1010-8.
- Abstract Viewed: 455 times